Hyperglycemia Clinical Trial
Official title:
Effect of a Beverage Comprised of Compounds From Olives on Post-prandial Blood Glucose Responses in Healthy Volunteers
Consumption of carbohydrate containing foods or sugary drinks brings about changes to the
blood glucose levels. After a meal or drink, blood glucose rises until it reaches a peak
concentration usually after 30 minutes. When the body senses the increase in blood glucose, a
hormonal process involving insulin takes place to ensure that the glucose is taken up from
the blood for storage and where it is needed for energy in the body. This process then brings
about a decrease in the concentration of glucose until it reaches approximately the starting
concentration. The original concentration of glucose is attained approximately 2 hours after
eating or drinking a carbohydrate food or sugary drink respectively in healthy people.
Different carbohydrates and sugary drinks have different effects on blood glucose response
depending on the amount as well as the type of carbohydrate. Those that give rise to a high
glucose response compared to a reference carbohydrate (usually glucose) are said to be high
glycaemic index (GI) foods and those with a lower glucose response compared to a reference
carbohydrate (usually glucose) are said to be low glycaemic index (GI) foods.
Research has shown that diets that give rise to a high glucose response are associated with a
number of abnormalities like increased risk of metabolic syndrome. Metabolic syndrome mostly
comprises of insulin resistance and glucose intolerance which gives an increased risk of type
2 diabetes. It also gives rise to other conditions like high blood pressure (arterial
hypertension), elevated blood insulin levels (hyper-insulinemia), elevated amounts of fat in
the liver (fatty hepatosis) and elevated amounts of lipids in the blood (dyslipidemia). After
type 2 diabetes become clinically apparent, the risk of cardiovascular disease also rises.
Research has also shown that foods/drinks which raise blood glucose levels gradually (low GI)
rather than rapidly (high GI) have health benefits which include reducing the risk of
metabolic syndrome. Laboratory studies have shown that polyphenols found in fruits,
vegetables and plant based foods have a positive effect on carbohydrate metabolism and can
lower the blood glucose levels.
This research will determine whether the presence of polyphenols in the diet has any lowering
effect on the blood glucose levels and hence the glycaemic index of foods. This will be
determined by asking volunteers to consume pomegranate polyphenols together with different
carbohydrate sources which will define the 6 different interventions. The blood glucose
response of bread will be determined initially as a control reference. All meals will be
consumed in random order.
Analysis will be done by measuring blood glucose response after consumption of the control
reference meal and the test meal containing polyphenols and then determining the incremental
area under the glucose curve.
THE SIX DIFFERENT INTERVENTIONS MAY OR MAY NOT BE COMBINED FOR PURPOSES OF PUBLISHING
RESULTS. EACH INTERVENTION WILL AIM TO HAVE AT LEAST 10 PARTICIPANTS.
The world health organisation has reported that over 220 million people suffer from diabetes
worldwide and that by the year 2030, this number will be doubled. The WHO also reports that
in 2004, about 3.4 million people died from high blood sugar. About 90% of all diabetes cases
is due to type II diabetes. Type 2 diabetes is largely due to overweight and lack of physical
activity characterised by high glucose levels (hyperglycaemia).
In the human diet, the source of blood glucose is carbohydrates. Dietary carbohydrate is
important to maintain glycaemic homeostasis and provides the most of the energy in the diets
of most people. The control of blood glucose is a hormonal process and it is very important
to human physiology. Hormonal processes involve the release of insulin from the β- cells of
the pancreatic cells which stimulates the uptake of glucose after a meal, to other tissues
either for utilisation (glycolysis) or to be stored in the liver as glycogen (glycogenesis).
When blood glucose falls below normal, glucagon is secreted from the pancreatic α-cells and
it promotes liver glucose production by inducing the generation of glucose from
non-carbohydrate substrates such as amino and fatty acids (gluconeogenesis) and the
generation of glucose from glycogen (glycogenolysis).
When the glucose homeostasis hormonal control fails, it entails high blood glucose levels
(postprandial hyperglycaemia) which can lead to metabolic syndrome which includes obesity,
impaired glucose tolerance (IGT), hypertension and dyslipidemia. Disturbance of glucose
homeostasis can also lead to other symptoms such as inflammation and oxidative stress at the
whole body level as well as disturbances of the functionality in several organs as well as
diabetes. Therefore, as much as carbohydrates are required in the human body as a major
source of energy, too much in the diet can have adverse health effects especially the one
with high glycaemic effect.
The proposed mechanism adapted from Aston, 2006 of how carbohydrates may affect human health
is that when there is a continual presence of high glycaemic index foods in the diet, this
gives rise to postprandial glucose rise as well as high insulin demand to act on the high
blood glucose levels in the blood. Postprandial glucose rise and high insulin demand may lead
to insulin resistance which is the major component of metabolic syndrome. High insulin demand
may also lead to β-cell failure which may also result in hyperglycaemia which is also a cause
of insulin resistance. Insulin resistance and hyperglycaemia are risk factors for metabolic
syndrome and diabetes type 2.
Scientific evidence suggest that postprandial hyperglycaemia in humans has a major role to
play in health priorities like type 2 diabetes and blood glucose control. It has been
reported that about 90% of all diabetes cases consist of type 2 diabetes. Apart from type I
and type 2 diabetes, there are other related conditions which include pre-diabetes (impaired
glucose tolerance (IGT) and impaired fasting glucose (IFG) as well as metabolic syndrome
(obesity, hypertension and insulin resistance). It has been reported that pre-diabetes and
metabolic syndrome increases the risk of developing cardiovascular disease and diabetes
mellitus. The glycaemic index was originally proposed with the aim of managing diabetes.
However, recent studies have shown that the GI has potential in the prevention of type 2
diabetes as well as in the treatment of metabolic syndrome. Research has shown that high GI
diets are associated with increased risk of developing type 2 diabetes. More research has
shown that high GI diet is associated with a number of abnormalities like increased metabolic
syndrome and insulin resistance. In the same way, a low GI diet is said to improve insulin
sensitivity but more research is needed to support this. A few studies have shown this to be
the case. However it was observed that it was difficult to know whether this was as a result
of improved insulin sensitivity, or improved insulin secretion or due to reduced rate of
glucose absorption.
Potential solution having anything in the diet that can either slow down the digestion and
absorption of carbohydrates can help reduce the risk. Among others, two potential solutions
are that of consumption of low glycaemic index foods or having ingredients in the diet that
can reduce the glycaemic index of foods as well as postprandial blood glucose levels. The
presence of inhibiting components in the diet that can reduce postprandial glucose can also
be a solution to reducing the risk. Drugs like acarbose are currently used in some countries
for the management of type 2 diabetes which act by inhibiting carbohydrate digestive enzymes.
However, the use of acarbose has side effects such as nausea, flatulence and diarrhoea. It
has been reported that polyphenols also have the potential to inhibit the rise in blood
glucose by hindering the rapid absorption of glucose.
A recent review has reported that research using animal models as well as a limited number of
human studies, have shown that polyphenols and polyphenol rich foods or beverages have the
potential to affect postprandial glycaemic responses and fasting glycaemia as well as an
improvement of acute insulin secretion and sensitivity. Other possible mechanisms as reported
in the review include pancreatic β- cells stimulation to secrete insulin as well as
activation of insulin receptors, modulation of the release of glucose from the liver as well
as of intracellular signalling pathways and gene expression.
Another recent review concluded that it is very possible that the effects of polyphenols in
the diet will affect glycaemic index of foods as well as postprandial glucose responses in
humans. The two mechanisms highlighted by which this can be achieved being the inhibition of
sugar metabolising enzymes as well as transporters. This potential action of polyphenols can
thus be compared to that of acarbose which acts by the same mechanism and research in chronic
intervention studies has shown that it reduces diabetes risk.
This research will involve the use of soluble olive powder as a source of polyphenols to
determine its effects on the glycaemic response when consumed together with a carbohydrate
source. Four interventions will be carried out as follows:
1. White bread as source of carbohydrate
2. Whole meal bread as source of carbohydrate
3. Glucose as source of carbohydrate
4. Sucrose as source of carbohydrate
5. White bread as source of carbohydrate but with 3 days high fat diet prior to the study
visit.
6. White bread as source of carbohydrate but with 3 days high carbohydrate diet prior to
the study visit.
The study was approved by the University of Leeds Mathematical and Physical Sciences (MAPs)
ethical committee with application number MEEC15-044. At least 10 volunteers will be
recruited for each intervention (white bread, whole bread, glucose, sucrose, 3 days high fat
diet, 3 days high carbohydrate diet). The volunteers will be screened for their fasting blood
glucose level. They will need to be healthy and their fasting blood glucose levels should
fall within the healthy range of 4.3-5.9mmol/L.
The volunteers are scheduled to attend 3 visits. During each visit, the volunteer comes
fasted in the morning and the fasting blood glucose is measured by the use of a glucometer.
The volunteer is then given a test meal which will be randomized and blood glucose will be
measured at 15, 30, 45, 60, 90, 120,150 and 180 minutes after the first bite of the test
meal. The results will be used to plot the area under the curve and results obtained after
consuming test meals will be compared to those obtained after consumption of control meals.
THE SIX DIFFERENT INTERVENTIONS MAY OR MAY NOT BE COMBINED FOR PURPOSES OF PUBLISHING
RESULTS. EACH INTERVENTION WILL AIM TO HAVE AT LEAST 10 PARTICIPANTS.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01267448 -
Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
|
Phase 4 | |
Recruiting |
NCT03775733 -
Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Hyperglycemia
|
N/A | |
Completed |
NCT03482154 -
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
|
||
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
Completed |
NCT00535600 -
Effects of Bariatric Surgery on Insulin
|
||
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Recruiting |
NCT02885909 -
Inpatient Blood Glucose Control in Taichung Veterans General Hospital
|
Phase 4 | |
Recruiting |
NCT02885922 -
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
|
||
Completed |
NCT02012465 -
Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients
|
Early Phase 1 | |
Withdrawn |
NCT01488383 -
Effect of Stevioside in Postpandrial Glucose in Healthy Adults
|
N/A | |
Completed |
NCT01805414 -
Breakfast Nutrition and Inpatient Glycemia
|
N/A | |
Completed |
NCT01803568 -
Skeletal Muscles, Myokines and Glucose Metabolism MYOGLU
|
N/A | |
Completed |
NCT01810952 -
The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
|
Phase 4 | |
Active, not recruiting |
NCT01247714 -
Clinical Evaluation of a Specific Enteral Diet for Diabetics
|
N/A | |
Not yet recruiting |
NCT00846144 -
The Reduction in Glucose Stimulated Insulin Secretion Induced by Cytokines May be Prevented by Copper Addition - Studies in Diabetic Patients
|
N/A | |
Completed |
NCT00996099 -
Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients
|
N/A | |
Recruiting |
NCT00654797 -
Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2
|
Phase 2 | |
Completed |
NCT00468494 -
Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?
|
N/A | |
Completed |
NCT00394407 -
Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes
|
Phase 4 |